Recently, Waters reported that its revenues in the third quarter were up 2 percent year over year, driven by broad-based demand in the life science markets. The company posted revenues of $500.6 million, and beati..

Epigenomics today announced that the US Food and Drug Administration has requested further data before making a decision on whether to approve the firm's blood-based colorectal cancer screening test. Epigenom..

The US Food and Drug Administration (FDA) have approved the first complementary diagnostic test to support use of OPDIVO (nivolumab) for non-squamous non-small-cell lung cancer (NSCLC) therapy. Historically, the o..

Recently，Nantong Egens Biotechnology Co., LTD. applied for listing on the new OTC market. Notice shows Weijun Ou, the president of Egens, holding 35.07% shares and Weiguo Ou, board director of Egens, holding 9.04% sh..

MDxHealth recently reported that its third quarter revenues increased 17 percent year over year, driven by sales of its ConfirmMDx for Prostate Cancer test. The Belgian molecular diagnostics firm reported total ..

PierianDx and Syapse are combining their respective products to provide an end-to-end genomic testing workflow for hospitals' pathology laboratories. The partners will integrate PierianDx's Clinical Genom..

Tute Genomics has acquired the assets of Knome for an undisclosed amount. Under the terms of the purchase agreement, Tute is integrating Knome's KnoSys technology with its cloud-based genome informatics and..

Infectious disease diagnostics firm DNAe today announced a bank facility of £25 million ($38.7 million) from Citibank, to fund the development of its point-of-care diagnostics for septic infections. The firm sai..

MacroGenics said today it has regained full global rights to the Phase I cancer compound enoblituzumab (MGA271), after Servier opted not to exercise its option to develop and commercialize the B7-H3-targeting monoclon..

Sigma-Aldrich said today it has acquired the Duolink® product portfolio from Olink Bioscience for an undisclosed price. The acquisition includes intellectual property, sales, marketing and manufacturing asset..

InDevR last week announced that it has received ISO 13485:2003 certification for the design, development, manufacture, and service of assays, instrumentation, and in vitro diagnostic devices. To obtain the certi..

Blood-testing start up Theranos, under fire after U.S. Food and Drug Administration inspectors found. Heavily redacted inspection reports were conducted Aug. 25 through Sept. 16, posted Oct.27 by the FDA, said Therano..

Igenica Biotherapeutics said recently it has launched an oncology research agreement with MedImmune to assess the potential of antibody-drug conjugates (ADCs) targeting surface antigen in leukemia (SAIL), a cell surfa..

The National Institutes of Health announced four new funding opportunities to support the development of innovative genomic technologies across a broad range of research areas including single-cell genomics, sample pr..

Recently, Sinocare said it has agreed to acquire Nipro Diagnostics Inc. a wholly-owned subsidiary of Nipro Corporation, with $272.5 million. According to the acquisition agreement, Nipro Corporation will keep purchasi..

Hologic today announced it has earned CE-IVD certification for its Aptima hepatitis C virus (HCV) Quant Dx assay. The transcription-mediated amplification-based assay, which runs on the Panther system, is certifi..

Ahead of a two-day public workshop on regulating next-generation sequencing tests, the US Food and Drug Administration has published discussion papers outlining the approaches it is considering and has asked stakehold..

Fueled by new information technology (IT) software that allows laboratories to test in new ways, the USD 102 billion global market for clinical laboratory services is rapidly growing and evolving, according to a new h..

Recently, Collective Health said today it’s taking a large new funding round from Google Ventures and others to offer its health insurance management platform to employers nationwide in 2016. The $81 million fun..

The UK's Precision Medicine Catapult recently announced the initial locations for its six regional centers of excellence: Belfast, Cardiff, Glasgow, Leeds, Manchester, and Oxford. The six centers will make up..